APO RESEARCH · REPORT
Glycomics & Glycobiology
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Product & engineering
Understand the product.
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Selected research
Industry Growth & Trends
Global Glycomics & Glycobiology Industry Growth and Trends Forecast to 2032
Market perspective
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
According to APO Research, the global Glycomics & Glycobiology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Glycomics & Glycobiology market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Glycomics & Glycobiology market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycomics & Glycobiology market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycomics & Glycobiology.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Glycomics & Glycobiology market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Glycomics & Glycobiology Market by Company
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Glycomics & Glycobiology Segment by Type
Instruments
Enzymes
Reagents
Kits
Glycomics & Glycobiology Segment by Application
Drug Discovery & Development
Diagnostics
Others
Glycomics & Glycobiology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Glycomics & Glycobiology companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Enzymes
- Reagents
- Kits
Applications
- Drug Discovery & Development
- Diagnostics
- Others
Companies covered
- ThermoFisher Scientific
- Danaher
- Shimadzu Corporation
- ProZyme
- Takara Bio, Inc.
- Agilent Technologies
- Bruker
- Promega
- Waters Corporation
- R&D Systems
- New England Biolabs
- Merck KGaA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Glycomics & Glycobiology Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Glycomics & Glycobiology Market Size by Region (2021-2032)
- 1.4.1 Global Glycomics & Glycobiology Market Size by Region (2021-2026)
- 1.4.2 Global Glycomics & Glycobiology Market Size by Region (2027-2032)
- 1.5 Key Regions Glycomics & Glycobiology Market Size (2021-2032)
- 1.5.1 North America Glycomics & Glycobiology Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Glycomics & Glycobiology Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Glycomics & Glycobiology Market Size Growth Rate (2021-2032)
- 1.5.4 South America Glycomics & Glycobiology Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Glycomics & Glycobiology Market Size Growth Rate (2021-2032)
2 Glycomics & Glycobiology Market by Type
- 2.1 Type Introduction
- 2.1.1 Instruments
- 2.1.2 Enzymes
- 2.1.3 Reagents
- 2.1.4 Kits
- 2.2 Global Glycomics & Glycobiology Market Size by Type
- 2.2.1 Global Glycomics & Glycobiology Market Size Overview by Type (2021-2032)
- 2.2.2 Global Glycomics & Glycobiology Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Glycomics & Glycobiology Market Size Forecasted by Type (2027-2032)
- 2.3 Global Glycomics & Glycobiology Market Size by Regions
- 2.3.1 North America Glycomics & Glycobiology Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Glycomics & Glycobiology Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Glycomics & Glycobiology Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Glycomics & Glycobiology Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Glycomics & Glycobiology Market Size Breakdown by Type (2021-2026)
3 Glycomics & Glycobiology Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug Discovery & Development
- 3.1.2 Diagnostics
- 3.1.3 Others
- 3.2 Global Glycomics & Glycobiology Market Size by Application
- 3.2.1 Global Glycomics & Glycobiology Market Size Overview by Application (2021-2032)
- 3.2.2 Global Glycomics & Glycobiology Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Glycomics & Glycobiology Market Size Forecasted by Application (2027-2032)
- 3.3 Global Glycomics & Glycobiology Market Size by Regions
- 3.3.1 North America Glycomics & Glycobiology Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Glycomics & Glycobiology Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Glycomics & Glycobiology Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Glycomics & Glycobiology Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Glycomics & Glycobiology Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Glycomics & Glycobiology Industry Trends
- 4.2 Glycomics & Glycobiology Industry Drivers
- 4.3 Glycomics & Glycobiology Industry Opportunities and Challenges
- 4.4 Glycomics & Glycobiology Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Glycomics & Glycobiology Revenue (2021-2026)
- 5.2 Global Glycomics & Glycobiology Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Glycomics & Glycobiology Key Company Headquarters & Area Served
- 5.4 Global Glycomics & Glycobiology Company, Product Type & Application
- 5.5 Global Glycomics & Glycobiology Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Glycomics & Glycobiology Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Glycomics & Glycobiology Players Market Share by Revenue in 2025
- 5.6.3 2025 Glycomics & Glycobiology Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ThermoFisher Scientific
- 6.1.1 ThermoFisher Scientific Company Information
- 6.1.2 ThermoFisher Scientific Business Overview
- 6.1.3 ThermoFisher Scientific Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
- 6.1.5 ThermoFisher Scientific Recent Developments
- 6.2 Danaher
- 6.2.1 Danaher Company Information
- 6.2.2 Danaher Business Overview
- 6.2.3 Danaher Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Danaher Glycomics & Glycobiology Product Portfolio
- 6.2.5 Danaher Recent Developments
- 6.3 Shimadzu Corporation
- 6.3.1 Shimadzu Corporation Company Information
- 6.3.2 Shimadzu Corporation Business Overview
- 6.3.3 Shimadzu Corporation Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
- 6.3.5 Shimadzu Corporation Recent Developments
- 6.4 ProZyme
- 6.4.1 ProZyme Company Information
- 6.4.2 ProZyme Business Overview
- 6.4.3 ProZyme Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
- 6.4.5 ProZyme Recent Developments
- 6.5 Takara Bio, Inc.
- 6.5.1 Takara Bio, Inc. Company Information
- 6.5.2 Takara Bio, Inc. Business Overview
- 6.5.3 Takara Bio, Inc. Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
- 6.5.5 Takara Bio, Inc. Recent Developments
- 6.6 Agilent Technologies
- 6.6.1 Agilent Technologies Company Information
- 6.6.2 Agilent Technologies Business Overview
- 6.6.3 Agilent Technologies Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
- 6.6.5 Agilent Technologies Recent Developments
- 6.7 Bruker
- 6.7.1 Bruker Company Information
- 6.7.2 Bruker Business Overview
- 6.7.3 Bruker Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bruker Glycomics & Glycobiology Product Portfolio
- 6.7.5 Bruker Recent Developments
- 6.8 Promega
- 6.8.1 Promega Company Information
- 6.8.2 Promega Business Overview
- 6.8.3 Promega Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Promega Glycomics & Glycobiology Product Portfolio
- 6.8.5 Promega Recent Developments
- 6.9 Waters Corporation
- 6.9.1 Waters Corporation Company Information
- 6.9.2 Waters Corporation Business Overview
- 6.9.3 Waters Corporation Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
- 6.9.5 Waters Corporation Recent Developments
- 6.10 R&D Systems
- 6.10.1 R&D Systems Company Information
- 6.10.2 R&D Systems Business Overview
- 6.10.3 R&D Systems Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
- 6.10.5 R&D Systems Recent Developments
- 6.11 New England Biolabs
- 6.11.1 New England Biolabs Company Information
- 6.11.2 New England Biolabs Business Overview
- 6.11.3 New England Biolabs Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
- 6.11.5 New England Biolabs Recent Developments
- 6.12 Merck KGaA
- 6.12.1 Merck KGaA Company Information
- 6.12.2 Merck KGaA Business Overview
- 6.12.3 Merck KGaA Glycomics & Glycobiology Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
- 6.12.5 Merck KGaA Recent Developments
7 North America
- 7.1 North America Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Glycomics & Glycobiology Market Size by Country (2021-2026)
- 7.3 North America Glycomics & Glycobiology Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Glycomics & Glycobiology Market Size by Country (2021-2026)
- 8.3 Europe Glycomics & Glycobiology Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Glycomics & Glycobiology Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Glycomics & Glycobiology Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Glycomics & Glycobiology Market Size by Country (2021-2026)
- 10.3 South America Glycomics & Glycobiology Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Glycomics & Glycobiology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Glycomics & Glycobiology Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst